Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
30.46
+0.48 (1.60%)
At close: Jul 10, 2025, 4:00 PM
29.65
-0.81 (-2.66%)
After-hours: Jul 10, 2025, 5:08 PM EDT

Alkermes Market Cap

Alkermes has a market cap or net worth of $5.02 billion as of July 10, 2025. Its market cap has increased by 20.51% in one year.

Market Cap
5.02B
Enterprise Value
4.21B
1-Year Change
20.51%
Ranking
Category
Stock Price
$30.46

Market Cap Chart

Since December 1, 1998, Alkermes's market cap has increased from $383.70M to $5.02B, an increase of 1,209.07%. That is a compound annual growth rate of 10.14%.

History

DateMarket Cap% Change
Jul 10, 20255.02B7.94%
Dec 31, 20244.65B0.52%
Dec 29, 20234.63B7.82%
Dec 30, 20224.29B14.15%
Dec 31, 20213.76B18.47%
Dec 31, 20203.18B-1.20%
Dec 31, 20193.21B-29.92%
Dec 31, 20184.59B-45.52%
Dec 29, 20178.42B-0.36%
Dec 30, 20168.45B-29.09%
Dec 31, 201511.91B39.10%
Dec 31, 20148.56B53.99%
Dec 31, 20135.56B127.59%
Dec 31, 20122.44B8.61%
Dec 30, 20112.25B91.59%
Dec 31, 20101.17B31.68%
Dec 31, 2009891.70M-12.16%
Dec 31, 20081.02B-36.29%
Dec 31, 20071.59B18.17%
Dec 29, 20061.35B-22.92%
Dec 30, 20051.75B37.76%
Dec 31, 20041.27B5.23%
Dec 31, 20031.21B197.29%
Dec 31, 2002405.90M-76.06%
Dec 31, 20011.70B-2.38%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 709.79B
Johnson & Johnson 379.41B
AbbVie 344.45B
Novo Nordisk 316.64B
UnitedHealth Group 271.70B
Novartis AG 243.81B
Abbott Laboratories 232.44B
AstraZeneca 223.49B
Market Cap Rankings